Quarterly report pursuant to Section 13 or 15(d)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.8.0.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Net loss $ 619,334 $ (3,784,777)  
Cash flows from operations 1,654,201 25,587  
Asset impairment charges 0 0  
Cash equivalents 0   $ 0
Restricted cash 781,310   778,579
Cash in excess of FDIC limits 3,089,397    
Allowance for doubtful accounts 200,000   200,000
Shipping and handling expense 319,024 157,359  
Shipping and handling charged to customers 85,489 41,956  
Allowance for customer returns 0   0
Inventory, noncurrent 4,314,860   5,667,101
Depreciation expense 110,196 47,525  
Research and development 153,704 188,716  
Advertising expense 181,644 66,900  
Unrecognized tax benefits 0   $ 0
Germany and The Netherlands [Member]      
Inventory, noncurrent $ 680,516    
Options [Member]      
Antidilutive shares outstanding 3,721,679    
Warrants [Member]      
Antidilutive shares outstanding 1,401,628    
Performance based stock options [Member]      
Stock that may be required to issue 10,750,000    
Consumer Products [Member]      
Research and development $ 116,634 49,033  
Specialty Pharmaceuticals [Member]      
Research and development $ 37,070 $ 139,683